Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:40 PM
Ignite Modification Date:
2025-12-24 @ 6:40 PM
NCT ID:
NCT06863857
Eligibility Criteria:
Inclusion Criteria
* Age ≥ 18 years
* Patients with histological or cytological diagnosis of clear cell RCC
* Patients with metastatic disease documented by imaging or biopsy of the secondary site
* Patients who have not had previous treatment for RCC
* Patients with an indication for first-line medical treatment based on IO+TKI, IO+IO as per clinical practice at the Medical Oncology Unit of the IRCCS University Hospital of Bologna
* Patients who have already had a dual-energy spectral total-body CT with MDC within 4 weeks of treatment initiation
* Availability of a formalin-fixed, paraffin-embedded histological block (FFPE) stored for a period \<15 years, for the execution of molecular analysis for the search for alterations of the genes ATM, BAP1, KDM5C, MET, MTOR, NF2, PBRM1, PIK3CA, PTEN, SETD2, SMARCB1, TP53, TSC1, TSC2, VHL
* Patients who knowingly express consent to participate in the study after signing the consent
Exclusion Criteria
-None
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06863857
Study Brief:
Protocol Section:
NCT06863857